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Protein oxidation is involved in regulatory physiological events as well as in damage to tissues and is
thought to play a key role in the pathophysiology of diseases and in the aging process. Protein-bound
carbonyls represent a marker of global protein oxidation, as they are generated by multiple different
reactive oxygen species in blood, tissues and cells. Sample preparation and stabilization are key steps in
the accurate quantiﬁcation of oxidation-related products and examination of physiological/pathological
processes. This review therefore focuses on the sample preparation processes used in the most relevant
methods to detect protein carbonyls after derivatization with 2,4-dinitrophenylhydrazine with an em-
phasis on measurement in plasma, cells, organ homogenates, isolated proteins and organelles. Sample
preparation, derivatization conditions and protein handling are presented for the spectrophotometric
and HPLC method as well as for immunoblotting and ELISA. An extensive overview covering these
methods in previously published articles is given for researchers who plan to measure protein carbonyls
in different samples.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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.Introduction
In recent years, more and more evidence has arisen that oxi-
dative processes play a key role in the pathophysiology of many
diseases and in the aging process. Besides regulatory events, a
plethora of damaging effects is induced by oxidative processes,
one of these damaging processes is protein oxidation [1]. Oxida-
tive damage to proteins results in a multitude of products (for
reviews see [2–6]), arising from modiﬁcation of a wide range of
amino acids. These include damage to sulfur-containing, aromatic,
and aliphatic amino acids [7–10] (Table 1). Protein carbonylsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Possible oxidation products of amino acid residues resulting in protein carbonyl
formation.
Amino acid Oxidation products
Proline Glutamic semialdehyde and other ring opened products
Arginine Glutamic semialdehyde and other side-chain products
Lysine Aminoadipic semialdehyde and other side-chain products
Threonine Carbonyls formed at side chain sites
Methionine Methional
Tryptophan N-formylkynurenine, kynurenine
Histidine 2-Oxo-histidine and ring-opened species
Alanine Formaldehyde and carbonyls from methyl group
Valine Acetone, formaldehyde and carbonyls on side-chain methyl
groups
Leucine Isobutyraldehyde, acetone, formaldehyde, and carbonyls on side-
chain
Aspartate Glyoxylic acid
Isoleucine Formaldehyde, carbonyls on side-chain
D. Weber et al. / Redox Biology 5 (2015) 367–380368represent an irreversible form of protein modiﬁcation and have
been demonstrated to be relatively stable (degradation/clearance
in hours/days) in contrast to lipid peroxidation products that are
removed within minutes [11,12]. In addition, protein carbonyls are
formed early during oxidative stress conditions and are not a re-
sult of one speciﬁc oxidant, thus they can be called a marker of
overall protein oxidation. Due to the great variety of different
modiﬁcations [13], one obstacle in the detection of protein-related
oxidative stress biomarkers is the requirement of complex proce-
dures for their determination. Furthermore, the instability of some
of these products as a result of repair processes (in the case of
methionine sulfoxides) [14] and by peroxiredoxins and disulﬁde
reductases [15] can contribute to difﬁculties in assessing and
quantifying oxidation status. It is worth pointing out that some of
the formed species resulting from protein oxidation (for-
maldehyde, acetaldehyde, acetone, etc.) do not remain protein
bound but are released. Hence they are not detected by any assays
that involve protein separation or precipitation. Depending on the
radical treatment used, released carbonyls can however be major
products [16].
Various oxidants may attack several amino acids and are thus
able to produce both protein-bound and released carbonyl groups
(Table 1 and Fig. 1). The yield of these species is however oxidantFig. 1. Protein oxidation resulting in protein carbonyl formation. Reactive oxygen species
cleavage of the protein backbone. Other possible formation routes of protein carbonyls ar
(Cys), histidine (His), arginine (Arg) and lysine (Lys) residues and thus introduce carbo
products with the same residues.dependent. Due to the structure of normal amino acids it is ex-
pected, that no carbonyl groups are part of a native protein.
However, this seems to be a simplifying assumption since many
proteins undergo (enzymatic) post-translational modiﬁcations
where carbonyl groups might be introduced into the native,
functional protein. The presence of such structures could be the
reason for the high basal (not stress-induced) level of protein
carbonyls found in some proteins. Furthermore, inappropriate
sample handling might contribute to elevated concentrations ob-
served in some studies.
The most commonly used marker to assess protein oxidation is
via the determination of protein-bound carbonyls. Protein carbonyls
can be detected by various methods, all relying on the derivatiza-
tion of the carbonyl group. The reduction with radiolabeled bor-
ohydride introduces a measurable radiolabel into the protein,
whereas several hydrazine derivatives, most commonly 2,4-dini-
trophenylhydrazine (DNPH, Fig. 2) or biotin hydrazine, introduce
detectable functional groups into the oxidized protein. So, the most
often used procedure to detect protein carbonyls is after their de-
rivatization with DNPH. During the last three decades most of these
methods have referred to the basic methods described by Levine
et al. [17,18] using the highly-sensitive DNP-modiﬁcation of protein
carbonyls followed by a detection either by spectrophotometric
methods, by an HPLC-based technique or using anti-DNP antibodies
in immunoblotting [19] or ELISA [20] (see Fig. 3). In addition to this,
proteomic techniques have been applied to get a more detailed
insight into the mechanism of protein damage, e.g. in blood [21].
In the following we will concentrate on the determination of
protein carbonyls in plasma, cell culture, organ homogenate and
isolated protein/organelle samples by the methods of Levine et al.
[17,18], Shacter et al. [19], Keller et al. [22] and Buss et al. [20].
As described above, DNP-derivatized proteins can be detected
by different methods; hence every laboratory should be able to
detect carbonyl groups either by the simple spectrophotometric
assay or by more complex procedures. The fact that no special
equipment is needed for the analysis of DNP-derivatized proteins
has led to the application of these methods in numerous pub-
lications. The search term “protein carbonyl” leads to more than
15,000 publications on PubMed and “protein carbonyl assay” still
leads to around 6000 results (accessed in April 2015).(ROS) may either react directly with some amino acid residues or lead to oxidative
e via the oxidation of lipids resulting in reactive aldehydes which react with cysteine
nyl groups and furthermore via the reaction of reducing sugars or their oxidation
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Fig. 2. Reaction of protein carbonyl group with 2,4-dinitrophenylhydrazine. The nucleophilic addition, also called condensation reaction, resulting in a 2,4-dinitrophenyl
hydrazone is shown for an oxidized lysine residue (aminoadipic semialdehyde). Note that the reaction is accompanied by the loss of one molecule of water.
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PubMed was accessed to view the publications of Levine
[17,18], Shacter et al. [19], Keller et al. [22] and Buss et al. [20].
Following this, on the bottom right hand side, the link “Cited by xx
PubMed Central articles” was followed to view all publications
citing one of these original method publications.
At the time PubMed was accessed in November 2013, the pub-
lication of Levine [17] was cited by 130 publications. Forty-four of
these were reviews or reported on research carried out with bac-
teria, plants, yeast, or non-human primates. Seventeen publications
referred to the method or the results in general in the introduction
or in the discussion of the publication and thus did not apply the
method. Five publications described using the commercial kit
(OxyBlot). Another 45 publications cited the spectrophotometric,
HPLC method or Western blot without any modiﬁcations or speciﬁc
comments on sample preparation and analytical condition; while
19 publications described in more detail the reaction conditions and
four publications the sample handling for the spectrophotometric
assay and the immunoblotting, respectively (see Table 2 and Fig. 4).
In November 2013, the method description for immunoblotting
by Emily Shacter et al. was cited by 38 publications. Fifteen ofFig. 3. Flow chart of possibilities to analyze protein carbonyls after DNP derivatization. S
qualitatively, depending on the research question and laboratory equipment/facilities. T
separated before derivatization or the other way around. Following separation/derivat
immunoblot is not mandatory and is usually followed by mass spectrometry. The right
and HPLC where standards are commonly used to assess the exact concentration of prothese publications were reviews or did not relate to human or cell
culture studies. Ten publications referred to results but not to the
method itself. Three publications applied a commercial kit. Ten
publications described the method with or without slight mod-
iﬁcations (see Table 3 and Fig. 4).
The method by Keller et al. [22] was cited by 10 publications.
Five of these were reviews or used yeast/houseﬂy models. Two
publications did not apply the method. Three publications de-
scribed applying the method of Keller et al. [22] and Shacter et al.
[19].
Some authors cited more than one reference/method when
describing the immunoblotting technique thus resulting in less
relevant publications in Table 3 than observed in Fig. 4.
The method description of Hendrikje Buss et al. [20] was cited
by 53 publications when accessed in November 2013. Twenty of
these publications only referred to the publication in the in-
troduction or discussion or did not describe using plasma/serum
or cell culture samples. Three publications described using a
commercial kit, while four did not go into further detail con-
cerning the application of the method. Twenty-six publications
described the method in detail with no modiﬁcations or only
slight changes (see Table 4).everal options exist to detect protein carbonyls in a sample, either quantitatively or
he left-hand side shows several ways of the so-called OxyBlot. The proteins can be
ization, immunoblot is carried out. If separation is performed with 2D PAGE, the
hand side depicts more quantitative methods: the spectrophotometric assay, ELISA
tein carbonyls in the sample.
Table 2
Published sample preparation for spectrophotometric determination of protein carbonyls (n.a.: not available, ratio of sample volume to DNP volume).
Species Sample preparation Derivatization conditions Protein handling Wave-length Levela Refs.
(Precipitation, washing, dissolving)
n.a. Oxidatively modiﬁed proteins (40.5 mg) 10 mM DNPH (in 2 M HCl
or in 6 M guanidine-HCl,
pH 2.5)ratio n.a.1 hn.a. if
under dark conditions
20% TCA Spectrum (360–390 nm) 0.2–1.0 mol/mol protein [17,18]
Ratio n.a. Washing with ethanol–ethyl acetate (1:1)
1 h 6 M guanidine
n.a. if under dark
conditions
Human Heparin plasma DNPH (concentration n.a.) n.a. 360 nm (280 nm) 1.02 nmol/mg [32]
80 °C Ratio n.a. Washing n.a.
Dilution n.a. Conditions/duration n.a. Guanidine n.a.
Human Serum 10 mM DNPH (in 2.5 M
HCl)
20% TCA n.a. 2.470.21 nmol/mg [33]
80 °C Ratio n.a. Washing with ethanol–ethyl acetate (1:1) 22,000 M1/cm
1:100 dilution Duration n.a. 6 M guanidine
Decomplementation at 56 °C for 30 min n.a. if dark
Human Plasma n.a. n.a. n.a. 0.48–0.7 nmol/mg [34]
80 °C In 96-well plates
Concentration n.a.
Human Plasma of children with juvenile chronic
arthritis
20 mM DNPH 20% TCA 360 nm Patients vs controls: 1.3670.68 vs 0.807
70.16 nmol/mg
[35]
Undiluted plasma Ratio (1:1) Washing with ethanol–ethyl acetate (1:1)
1 h 6 M guanidine
Human Mesenchymal stem cell (hMSCs) suspensions 10 mM DNPH 20% TCA (v/v) 360 nm 20–70 mmol/103 cells [36,37]
30% TCA precipitate resuspended in DNPH 1 h (37 °C) Washing with ethanol–ethyl acetate (1:1)
Concentration n.a. Guanidine in 2 mM phosphate buffer
Human Acute promyelocytic leukemia (APL)-derived
NB-4 cells soluble protein fraction with pro-
tease inhibitors, sonicated
10 mM DNPH 20% TCA 370 nm 3.5 nmol/mg [38]
Stored at 20 °C Ratio (1:6) Washing with ethanol–ethyl acetate (1:1)
Concentration n.a. 1 h (20 °C) in the dark 6 M guanidine
Mouse Neutrophil cell lysate in 50 mM potassium
phosphate (pH 7.4)
High DNPH (in 2 M HCl) 20% TCA 370 nm 10–30 nmol/mg [28]
Concentration n.a. Ratio n.a. Washing with ethanol–ethyl acetate (1:1)
1 h in the dark 6 M guanidine
Mouse Peritoneal macrophage cell lysate in 50 mM
potassium phosphate (pH 7.4)
High DNPH (in 2 M HCl) 20% TCA 370 nm 5–12 mmol/mg [27]
Concentration n.a. Ratio n.a. Washing with ethanol–ethyl acetate (1:1)
1 h in the dark 6 M guanidine
Conditions n.a.
Mouse Brain cortex homogenate extracts in phosphate
buffer (pH 7) with DTT and EDTA
DNPH n.a. 370 nm in 96-well plate 0.2–0.4 nmol/mg [39]
Streptomycin substrate (10%) to remove nucleic
acids
Ratio, duration and dark
conditions n.a.
Concentration n.a.
Mouse Lysate of primary cortical neurons in phosphate
buffer (pH 6.5)
1 DNPH (in 2 M HCl) 10% TCA 375 nm Expressed as fold-increase to controls [40]
Lysis and storage n.a. Ratio n.a. Washing with ethanol–ethyl acetate (1:1)
Concentration n.a. 20 min at RT 6 M guanidine in 20 mM sodium phos-
phate buffer (pH 6.5)
Mouse Serum and kidney homogenate (in PBS, pH 7.4,
containing protease inhibitor cocktail)
10 mM DNPH (in 2.5 M
HCl)
20% TCA 370 nm 3-Fold increase in protein carbonyls
in mice treated with tetrachlorethene
[41]
Undiluted serum Ratio (1:4) Washing with ethanol–ethyl acetate (1:1)
1 h at RT in the dark 6 M guanidine
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D. Weber et al. / Redox Biology 5 (2015) 367–380 371These relevant publications were further examined for sample
origin and derivatization conditions etc. to allow better compar-
ison of results as well as for ﬁnding an appropriate protocol for
scientists planning future experiments.
Spectrophotometric and HPLC determination of protein carbonyls
after dinitrophenyl hydrazine modiﬁcation
The most-cited (original) method for derivatizing carbonyl
groups with different agents to determine the carbonyl content
was described by Levine in 1990 [17]. The publication discusses
the reaction of carbonyls with borohydride, DNPH, ﬂuorescein
thiosemicarbazide and ﬂuorescein amine.
In this protocol different oxidatively modiﬁed proteins
(40.5 mg protein) are treated with 10 mM DNPH for 1 h. The ratio
of sample volume to DNPH volume is not stated. The protein is
precipitated with 20% TCA followed by a washing step with
ethanol–ethyl acetate (1:1) and dissolving in 6 M guanidine. The
protocol for DNP derivatization is completed by the spectrum
measurement from 360 to 390 nm.
Another publication of Levine, published 4 years later (1994),
also describes the derivatization with DNP followed by HPLC
measurement and/or immunoblotting [18].
The general drawbacks of the spectrophotometric assay are
that the method is rather work-intensive, time-consuming and
high throughput measurement is not possible. Additionally, the
requirement of protein and volume is relatively high, accompanied
by the fact that the loss of acid-soluble proteins during washing
steps (about 10–15%) must be considered and the results adjusted
to the actual protein concentration. Furthermore additional car-
bonyl groups may also be introduced due to acidic conditions, DNP
may be trapped in the protein pellet and the resolubilization may
be incomplete, thus falsifying the results [23].
Another general problem is that nucleic acids may interfere as
they also contain carbonyl groups, and in addition other biological
compounds such as hemoglobin, myoglobin and retinoids absorb
at 370 nm which result in high background readings.
Since there are no established commercially available protein
standards of reduced and oxidized BSA to include as controls it is
difﬁcult to compare results obtained with the spectrophotometric
assay (and other methods) in different laboratories.
Some of these drawbacks can be overcome by HPLC analysis
which provides the advantages that DNP absorbance can be
monitored at 366 nm in parallel to protein absorbance at 280 nm.
Here DNP derivatization should be carried out in sodium dodecyl
sulfate (SDS) since guanidine–HCl is not suitable for most columns.
Detection of protein carbonyls by immunoblotting
In 1994 Shacter and Levine et al. published the immunoblotting
method to detect carbonyls of plasma proteins [19]. Here they
describe the preparation of standards with iron and ascorbate as
oxidizing agent. Heparin plasma was then treated with 10 mM
DNPH (in 10% TCA) for 15–30 min at room temperature. The se-
paration was performed with an SDS-PAGE (4–12% gradient) fol-
lowed by blotting onto a nitrocellulose membrane by standard
procedures. A monoclonal anti-DNP IgE, a secondary biotinylated
rat anti-mouse IgE and biotin–avidin-peroxidase complex were
used to detect DNP-carbonyl epitopes.
The publication is a general method description which uses
different oxidized proteins. Fibrinogen was identiﬁed as a major
oxidized protein in plasma. The amount of carbonyls present in
untreated plasma samples was 0.6 nmol/mg. Native, as well as
oxidized glutamine synthetase were run to assess the sensitivity of
the assay which was found to be 30 ng of protein.
Keller et al. developed an independent immunoblotting
Fig. 4. Final number of publications highlighted in Tables 2–4. As described in the search strategy, PubMed was accessed in November 2013 to view the publications of
Levine, Shacter et al., Keller et al., and Buss et al. as well as all publications citing one of these original method publications. The extracted publications were grouped into
categories (review, bacteria, plants; did not apply method; commercial kit; method applied but not described; relevant publication describing sample preparation etc.).
D. Weber et al. / Redox Biology 5 (2015) 367–380372protocol relying on the DNP-reaction [22]. Here, the authors oxi-
dize BSA with H2O2/vanadyl and radiolysis and derivatize the
samples with an equal volume of DNP for 1 h. SDS-PAGE is fol-
lowed by blotting on nitrocellulose and detection with BCIP and
NBT. The results show that the oxidation results in a linear in-
crease in carbonyl concentration in the albumin molecule and the
method is clearly more sensitive than the spectrophotometric
assay.
Optimizing the immunoblotting method can be quite time-
consuming. One must decide whether to perform pre- or post-
electrophoresis derivatization and consider the different types of
membranes. In terms of membrane choice, nitrocellulose mem-
branes should only be used when derivatization is carried out
before SDS-PAGE and immunoblotting because the membrane is
not suitable for incubation in strong acids. The derivatization time
is also crucial and varies signiﬁcantly between laboratories (see
Table 3). Concerning post-electrophoresis derivatization; Robinson
et al. note that the membrane should be treated with DNP for
exactly 5 min at RT [24], which is also our recommendation.
Both approaches, the pre- and post-electrophoresis derivati-
zation have limitations. They both involve numerous washing
steps making the approaches very time-consuming. The post-
electrophoresis derivatization requires several pre-treatment steps
(methanol, HCl) of the membrane. The pre-electrophoresis deri-
vatization is not recommended for samples with a low protein
concentration which will result in problems with loading the
pockets and in separating/visualizing low-molecular weight
proteins.
Because carbonyl groups are present in every molecule there
are problems with the reproducibility and the analysis of the
bands, furthermore the membranes often show a high back-
ground. The acidic derivatization affects the pI and hence com-
plicates the identiﬁcation of proteins in 2D PAGE.
An accurate determination of the carbonyl concentration is not
possible with immunoblotting. Therefore the results should al-
ways be expressed in relation to appropriate controls/samples and
theoretically, a control which has not been treated with DNP must
be included in every assay.
Using ELISA to determine protein carbonyls
Buss et al. described the use of an anti-DNP antibody in an
ELISA for the ﬁrst time in 1997. Standards of HOCl-oxidized and
sodium borohydride-reduced BSA are prepared for a standardcurve. It is important to note that the blocking step is carried out
with reduced BSA (original publication) and only with PBS in the
original publication and in the erratum, respectively. The original
publication contained errors concerning the preparation of re-
duced BSA [20], i.e. the ten-fold amount of NaBH4 and the four-
fold amount of BSA are described in the original publication.
Plasma from healthy and critically ill patients was diluted to
4 mg/ml and treated with 10 mM DNPH for 45 min at RT. The ratio
of sample volume to DNPH volume was 1:4. Samples were coated
onto MaxiSorp plate and detected with a biotinylated anti-DNP
and streptavidin-biotinylated-HRP. The fully reduced BSA showed
a carbonyl concentration of 0.6 nmol/mg, this concentration has
also been stated by Shacter et al. [19]. There was a linear corre-
lation (r¼0.70) between the absorbance of the spectro-
photometric assay (375 nm) and the ELISA for plasma samples
(n¼26). After subtracting the absorbance of the blank (reduced
BSA), plasma protein carbonyl concentration of healthy controls
was in the range of 0.06 nmol/mg whereas that of patients was
around 0.75 nmol/mg.
A modiﬁcation of the protocol described by Buss et al. is the
method by Alamdari [25]. Here the samples are adsorbed onto the
plate prior to derivatization. This is especially interesting for
samples with low protein concentrations (5 mg/ml).
Of the immunological methods, ELISA methods allow the si-
multaneous quantiﬁcation of a great number of samples and re-
quire only small sample volumes. They can be used for the mea-
surement of carbonyl concentrations not only in plasma, but also
in tissues and cell culture samples.
Limitations of this approach include that the determination of
the protein concentration is mandatory before carrying out the
assay and the assay takes 2 days because the samples are usually
adsorbed to the plate overnight. In addition the in-between
washing steps promote the risk for loss of sample. Many compa-
nies offer ELISA plates with different binding capacities for dif-
ferent requirements, e.g. for molecules with hydrophobic, hydro-
philic or mixed domains.
The available different monoclonal as well as polyclonal anti-
bodies also represent a problem since they all potentially react
with different epitopes. However, when the carbonyl groups of a
protein are chemically reduced, e.g. by borohydride, there is less
binding of DNP and hence also less antibody binding resulting in
low signal intensity [26] so antibody bias is of limited relevance.
As every laboratory uses its own standards accompanied by the
lack of available uniform and accepted protein standards resulting
Table 3
Measurements of protein carbonyls by immunoblotting.
Species Sample preparation Derivatization Gel, PAGE, membrane proteins
amount, transfer/blot
Antibody Level/result Refs.
Ratio (sample/DNP)
Conditions
Human Heparin plasma 10 mM DNPH (in 10% TCA) SDS-PAGE (4–12% gradient) Monoclonal anti-DNP IgE (Sigma), biotinylated
rat anti-mouse IgE
Method description, different oxidized
proteins
[19]
Nitrocellulose membrane (Southern Biotechnologies),
and biotin–avidin-peroxidase
complex (Vector Laboratories)
Blotting by standard
procedures
Human Serum Post-electrophoresis
derivatization
10% SDS-PAGE Anti-DNP (Molecular Probes) To compare pre- and post-electrophoresis
derivatization
[47]
0.5 mM DNPH Protein amount n.a. Goat anti-rabbit HRP-conjugate (Sigma)
Nitrocellulose and PVDF
membranes
Human Lysed SH-SY5Y cell supernatant 20 mM DNPH (in 2 M HCl)
sample in 12% SDS (1:1)
SDS-PAGE (10% and 15%) Polyclonal rabbit anti-DNP (Invitrogen) Exposure of Sphingosine Kinase 1 to TNFα
caused substantial carbonylation
[48]
Ratio (1:1) 30 mg soluble and 5 mg puriﬁed
protein
Anti-rabbit HRP-conjugate
For 45 min at 25 °C PVDF membrane
Precipitation of protein in
chloroform/methanol
Rabbit Puriﬁed muscle actin, total protein of
SH-SY5Y cell extracts, and actin im-
mune-precipitated from SH-SY5Y cells
centrifuged soluble protein from cell
extracts
20 mM DNPH (in 2 M HCl) SDS-PAGE and 2D Nu-PAGE (4–
12%)
Polyclonal rabbit anti-DNP (Invitrogen) Considerable actin carbonylation in SH-SY5Y
cells acutely exposed to TNFα or IL-1β
[49]
Sample in 12% SDS (1:1) 30–50 mg soluble and 5 mg
puriﬁed protein
Secondary Ab n.a.
(30 min, 25 °C) PVDF membrane
Ratio (1:1)
Human Acute promyelocytic leukemia (APL)-
derived NB-4 cells soluble protein
fraction
10 mM DNPH 12% gel Anti-DNP Treatment of NB4 cells with increasing con-
centrations (0.5–6 M) of As2O3 leads to in-
creased protein carbonyls
[38]
Sample in lysis buffer containing 6% SDS
(pH 7.2)
Ratio (1:1, 15 ml:14 ml) Nu-PAGE AP-conjugated anti-rabbit IgG
For 10 min at RT 25 mg protein
Nitrocellulose membrane
Human HeLa cell extract 10 mM DNPH Dot-Blot microﬁltration appa-
ratus and TransBlot transfer
membrane (Bio-Rad)
Anti-DNP (Dako) Slightly increased carbonylation in cells
lacking glutaredoxin 1
[50]
1 mg/ml Ratio (1:4) AP-conjugated anti-rabbit (Dako)
30 min at RT
Human Alzheimer’s disease brain homogenates 20 mM DNPH % n.a. Rabbit anti-DNP (Millipore) Different proteins carbonylated in AD on
comparison to age-matched controls
[51]
Ratio (1:4) SDS-PAGE Goat anti-rabbit IgG (Sigma)
20 min at 25 °C 150 mg protein
Nitrocellulose membrane
Semi-dry transfer
Human Bronchoalveolar lavage (BAL) ﬂuid OxyBlot kit (Chemicon
Inc.)
10% SDS-PAGE Anti-DNP Amount of carbonylated albumin per mg
total albumin in BAL ﬂuid was four times
higher in older current smokers and three
times higher in older former smokers than
in age matched non-smokers
[52]
Human Colon cells (SW620) Post-electrophoresis 5 mg protein/slot Anti-DNP-KLH, rabbit IgG (H&L) fraction Development of an immunochemical [24]
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Table 3 (continued )
Species Sample preparation Derivatization Gel, PAGE, membrane proteins
amount, transfer/blot
Antibody Level/result Refs.
Ratio (sample/DNP)
Conditions
derivatization: 10 mg/ml
DNPH (≙0.5 mM) in 2 M
HCl
(Molecular Probes) technique for the quantiﬁcation of carbonyl
groups in protein samples from small tissue
samples and cell cultures
min at RT PVDF membrane Peroxidase-conjugated F(ab′)2 fragment donkey
anti-rabbit IgG (H&L) fraction (Jackson Im-
munoresearch Laboratories)
Slot-blot
Mouse and
human
C57BL mouse tissue and human
ﬁbroblasts
DNPH/TFA from OxyBlot
Kit (Oncor)
% n.a. From the OxyBlot Kit Improve methods [53]
Ratio (1:1) SDS-PAGE
15 min at RT Protein amount n.a.
Nitrocellulose and PVDF
membrane
Semi-dry blotting
Mouse Cortical neuron homogenate and lysate n.a. 12.5% SDS-PAGE Anti-DNP kit (Chemicon Inc.) Relative to control [40]
20 mg 20 mg
Nitrocellulose membrane
Mouse Isolated collagen 0.5 mM DNPH 6% slab gel Rabbit anti-DNP (Sigma) Induced damage to collagen after treatment
with peﬂoxacin
[54,55]
Ratio (1:1) SDS-PAGE AP-conjugated goat anti-rabbit IgG (Sigma)
1 h at RT 50, 15 or 7 mg collagen
PVDF membrane (Sigma)
Trans-Blot apparatus
Mouse Mitochondria from Heat Shock factor 1
(Hsf1) knockout mice
10 mM DNPH % n.a. Rabbit anti-DNP (Sigma) Higher extent of carbonylation in mi-
tochondrial proteins of Hsf1 knockout mice
[56]
Ratio n.a. SDS-PAGE HRP-labeled goat anti-rabbit IgG
60 min at RT Protein amount n.a.
PVDF membrane
Mini trans-blot electrophoretic
transfer cell (Bio-Rad)
Rat Serum 20 mM DNPH (in 10% TFA) % n.a. Goat anti-DNP (Bethyl Laboratories Inc.) Changes in serum levels of total protein
carbonylation correspond to cardio-protec-
tive activity
[57]
Ratio (1:1) SDS-PAGE Donkey anti-goat IRDye 800CW (Li-COR)
10 min at RT 5 mg protein
PVDF membrane
Rat Mitochondria from head homogenate
(male, weanling Sprague-Dawley rats)
OxyBlot Kit 10% SDS-PAGE Anti-DNP (OxyBlot Kit) Comparison between rats with copper deﬁ-
cient diets (reduced carbonyls in copper
deﬁciency)
[58]
6 mg protein HRP-coupled anti-sheep IgG (Amersham)
PVDF membrane
Semi-dry transfer
Rat Ovary tissue sections 10 mM DNPH (in 10% TFA) 12% SDS-PAGE Rabbit anti-DNP Increased protein carbonyls were detected in
ovaries of rats exposed to tetrachlorethylene
water for 2 weeks compared to controls
[59]
Ratio n.a. 25 mg protein Biotinylated anti-rabbit (Vectastain ABC-AP kit)
45 min PVDF membrane
Tank blot
Rat and cow Histones from PC12 cells (rat) and thy-
mus, liver, spleen (bovine)
10 mM DNPH (in 10% TFA) % n.a. Anti-DNP (Dako) Higher carbonylation in untreated histone
H1 in comparison to core histone
[60]
Ratio (1:1) SDS-PAGE Goat anti-rabbit conjugated with HRP (Jackson
Immunoresearch Laboratories)
20 min at RT 5 mg protein
Nitrocellulose membrane
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The described assays require no speciﬁc equipment and can be
adapted to actual laboratory facilities and any methods which are
applicable in the respective laboratory can be used.
As mentioned above, each method has its limitations.
Besides these, there are some other facts that must be con-
sidered. As shown in Tables 2–4, the applied protocols differ
considerably in important details such as the protein concentra-
tion, ratio of sample volume to DNP volume, DNP concentration
and incubation duration, temperature and conditions.
The biggest difference between these various assays lies in the
derivatization step. The DNPH concentration for the spectro-
photometric assay is often used according to Levine, i.e. 10 mM,
equal to 0.2%, but 20 mM has also been used. Two groups state
excessively high DNP derivatization concentrations [27,28]. For
ELISA 10 mM seems to be the most practical concentration, while
for immunoblotting 10 and 20 mM are most frequently used. For
the case that the derivatization is carried out after SDS-PAGE or
adsorption of samples onto ELISA plate the DNP concentration is
signiﬁcantly lower: 0.5 and 0.05 mM DNPH, respectively. Besides
the concentration, the ratio of sample volume to DNP volume is
not consistent as it varies between equal volumes, 1:3, 1:4, 1:5 and
1:6. However, often this information is not stated at all. Ad-
ditionally the protein concentration or dilution of the sample is
often not stated, nevertheless this should be considered as the
protein concentration and DNP concentration should be adjusted/
correspond.
Furthermore the inﬂuence of the incubation temperature
should be considered. While some authors do not state any tem-
perature, most authors keep their samples at RT (or close to RT:
20 °C, 25 °C) but 37 °C is also frequently used, perhaps because it is
easier to keep this temperature constant. The next critical point is
the duration of incubation: Levine suggests incubating the sample
for 1 h. However, other authors apply incubation times of as short
as 5 min. For ELISA, most authors incubate their samples between
45 and 60 min. This seem to be relatively comparable, however
samples for the spectrophotometric assay are incubated between
15 and 60 min, and those for immunoblotting even differ between
5 and 60 min. We suggest incubating the samples for ELISA and
spectrophotometric assay for 45–60 min and mixing the samples
every 15 min (or applying constant agitation) to help minimize
differences in protocols.
The results, even if theoretically measured by the same proto-
col, are difﬁcult to compare, as the levels, shown in Tables 2–4, are
often not given in the same concentration.
The immunoblotting method does not of course give quanti-
tative data (i.e. absolute concentrations). The results of the spec-
trophotometric method, which could easily be given in as mol/mg
(depending on the concentration of a native or treated sample) are
frequently displayed in different units, e.g. mol/mol protein, nmol/
mg, mmol/mg or mmol/10³ cells. Some authors only present their
results expressed as fold-increase or percentage to controls. The
units for ELISA results are given as nmol/mg, pmol/mg, nmol,
nmol/ml, nmol/g, nmol carbonyl groups ﬁbrinogen/mg of plasma
proteins or carbonyl residues/HSA molecule. Some authors state
their results as arbitrary units, relation to control, and relative
amount. This makes it especially difﬁcult to compare results and is
also odd since the original protocol uses the unit pmol/mg and this
should be easily achieved by diluting all samples to the same
protein concentration and preparing standards of known carbonyl
concentrations.
The protein carbonyl concentration of a given sample reﬂects a
Table 4
Determination of protein carbonyls by ELISA.
Species Sample preparation Derivatization Antibody Plate producer Level* Ref
Human Plasma from healthy and critically ill pa-
tientsdiluted to 4 mg/ml
10 mM DNPH (in 6 M guanidine HCl,
0.5 M potassium phosphate buffer, pH
2.5)
Biotinylated anti-DNP (Molecular
Probes)
MaxiSorp (Nunc) 0.06–0.75 nmol/mg [20,62]
Ratio sample/DNPH (1:4) Streptavidin-biotinylated-HRP
(Amersham)
45 min at RT
Human Plasma from sepsis patients vs controls n.a. Biotin-conjugated polyclonal anti-DNP
IgG
n.a. 0.32–0.45 nmol/mg [63]
Dilution n.a. Streptavidin-conjugated HRP
Human Citrate-plasma from schizophrenia patients
and healthy volunteers
n.a. n.a. n.a. 0.178–0.482 nmol/mg [64]
Dilution n.a
Human Heparin and EDTA plasma and urine n.a. n.a. n.a. Signiﬁcantly higher concentration in blood of subway
workers and bus drivers than in ofﬁce workers (17 and
18 vs. 15 nmol/ml)
[65]
Dilution n.a.
Human Plasma from 71 hepatocellular carcinoma
patients and 694 controls
n.a. n.a. n.a. 0.11–1.41 nmol/mg [66]
Dilution n.a.
Human Plasma of chronic obstructive pulmonary
disease (COPD) patients
n.a. Polyclonal rabbit anti-DNP (Molecular
Probes)
MaxiSorp (Nunc) 17.972.9 nmol/mg [67]
4 mg/ml HRP-conjugate (Amersham)
Human Plasma from participants of the New York
Early Lung Cancer Action Project
n.a. Polyclonal rabbit anti-DNP (Molecular
Probes)
n.a. 17 nmol/ml [68]
4 mg/ml HRP-conjugate (Amersham)
Human Plasma 10 mM DNPH (in 6 M guanidine–HCl,
0.5 M potassium phosphate, pH 2.5)
Biotinylated anti-DNP (Molecular
Probes)
ELISA (Corning
Costar)
11–15.3 nmol/mg [69]
4 mg/ml Ratio and conditions n.a. Streptavidin–biotin HRP (Amersham)
Human Serum from middle-aged obese subjects Concentration and conditions n.a. n.a. n.a. 0.12 arb. u. [70]
4 mg/ml Ratio (1:4)
Human Heparin plasma 0.05 mM DNPH (in H3PO4, pH 6.2) Anti-DNP (Sigma) n.a. Method for measuring protein carbonyl in samples with
low amounts of protein
[25]
5 mg/ml 45 min at RT in the dark Anti-rabbit HRP-linked IgG (H&L, Up-
state Cell Signaling)
NOTE: derivatization after samples have
adsorbed to the plate!
Human Plasma and LDL n.a. Anti-DNP (Dako) n.a. Modiﬁcation of method [71]
Dilution n.a. Goat anti-rabbit IgG peroxidase con-
jugate (Sigma)
Human Plasma n.a. n.a. n.a. 0.1–0 5 nmol carbonyl groups ﬁbrinogen/mg of plasma
proteins
[72]
Dilution n.a.
Human Plasma from women with preeclampsia and
controls
45 min at RT Rabbit anti-DNP-KLH (Invitrogen) n.a. Signiﬁcantly higher concentration in cases than in
controls
[73]
Dilution n.a. HRP-conjugated porcine anti-rabbit IgG
(Dako A/S)
Human Plasma n.a. Biotinylated anti-DNP (Molecular
Probes)
n.a.
o11.5 nmol/ml up to 419.2 nmol/ml
[74]
4 mg/ml Streptavidin-biotinylated HRP-conjugate
(Amersham)
Human K562 cell lysates (human chronic myelo-
genous leukemia)
n.a. Rabbit anti-DNP IgG antiserum (Sigma) n.a. Relation to control [75]
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1 mg/ml in lysis buffer with 1 mM BHT Monoclonal anti-rabbit peroxidase-con-
jugated IgG (Sigma)
Human Parenchymal lung tissue of current smokers
with chronic obstructive pulmonary disease
n.a. Plate was pre-incubated with mouse
anti-HSA before addition of samples
n.a. 0.5–5 carbonyl residues/HSA molecule [76]
Dilution n.a. rabbit anti-DNP
Anti-rabbit HRP-conjugate
Human MRC-5-ﬁbroblast cell lysates (fetal lung) n.a. Anti-DNP rabbit-IgG-antiserum (Sigma) n.a. 1.5–3.2 nmol/mg [77]
4 mg/ml Monoclonal anti-rabbit-IgG-peroxidase
conjugated (Sigma)
Mouse Brain, liver, heart and spleen homogenates
from 6-week-old male DDY mice
10 mM DNPH (in 2 M HCl) n.a. n.a. Relation to control [78]
1 mg/ml For 1 h at RT
Ratio n.a.
Mouse Heart tissue homogenate of SAMP8 mice n.a. Rabbit anti-DNP IgG-antiserum (Sigma
Aldrich)
n.a. 664737 nmol/g (high-polyphenol diet) and 958770
(low-polyphenol diet) nmol/g
[79]
Dilution n.a. Monoclonal anti-rabbit IgG peroxidase
conjugate (Sigma Aldrich)
Mouse Mesenchymal stem cells derived from adi-
pose tissue of C57/Black6 mice
n.a. n.a. n.a. 4–32 Carbonyls/mg protein [80]
Dilution n.a.
Mouse Brain homogenate from ApoD-knockout
mice
n.a. Biotinylated anti-DNP (Molecular
Probes)
n.a. Relation to control [81]
Dilution n.a. Streptavidin-biotinylated HRP
(Amersham)
Mouse Isolated mitochondria from livers of Bcs1lG/
G mice
Concentration and ratio n.a. Anti-DNP (Invitrogen) n.a. 1.0970.36 relative amount [82]
Dilution n.a. 45 min at RT Swine anti-rabbit IgG-HRP (Dako A/S)
Mouse Retinal pigmented epithelial cell lysates 10 mM DNPH (in 6 M guanidine–HCl,
0.5 M potassium phosphate, pH 2.5)
Polyclonal rabbit anti-DNP (Molecular
Probes)
MaxiSorp (Nunc) 0.6–1.2 nmol [83]
4 mg/ml Ratio (1:4) HRP-conjugate (Amersham)
45 min at RT
Mouse RAW264.7 murine macrophage-like cells Kit from Cell Biolabs Kit from Cell Biolabs Kit from Cell
Biolabs
Results not signiﬁcant [84]
Dilution n.a.
Mouse HT22 cell lysates4 mg/ml in lysis buffer with
1 mM BHT
n.a. Rabbit anti-DNP IgG antiserum (Sigma) n.a. 6.5–9.0 pmol/mg [85]
Monoclonal peroxidase-conjugated
anti-rabbit IgG (Sigma)
Rat Ileal mucosa of salmonella infected rats n.a. Biotinylated anti-DNP (Molecular
Probes), streptavidin-biotinylated HRP
(Amersham)
MaxiSorp (Nunc) 0.1–0.2 nmol/mg [86]
4 mg/ml
n.a. Ferritin (10 mM in 6 M guanidine HCl, 0.5 M
potassium phosphate, pH 2.5)
Biotinylated anti-DNP MaxiSorp(Nunc) 0.55–1.0 nmol/mg [87]
Dilution n.a. Ratio (1:3) Anti-rabbit-IgG-peroxidase (γ-chain
speciﬁc)
45 min at RT
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D. Weber et al. / Redox Biology 5 (2015) 367–380378snapshot of generated and removed carbonyls. Protein carbonyls
are not only a result of amino acid oxidation but can also arise
from secondary reactions by nucleophilic addition of aldehydes or
reducing sugars and their oxidation products. Scientists must
evaluate whether they are interested in the oxidation of a speciﬁc
cellular or circulating protein or want to compare the carbonyl
content in blood of many samples, e.g. in clinical studies.
Theoretically, due to steric reasons the DNP molecule should
not be able to attack all carbonyl moieties in a similar way.
However, the derivatization of carbonyl compounds with DNP has
been used since the late 1950s [29]. We are not aware of any
publication studying the differences in terms of yield and rate of
the reaction between DNP and different carbonyl moieties.
The so-called OxyBlot is semi-quantitative but has shown the
best sensitivity and speciﬁcity [30], and is especially applicable in
cell culture studies. On the other hand ELISA seems to be best-
suited for clinical studies and the inclusion of external standards
allows standardization, better comparison, as well as high-
throughput. Nevertheless this decision depends on the laboratory
equipment and research question.
MS-based methods are inevitable when the aim is to identify
speciﬁc carbonylated residues of single proteins. However, not
every laboratory is able to apply MS and for some research ques-
tions it is also not practicable, e.g. in clinical/epidemiological stu-
dies where high-throughput of complex protein mixtures such as
plasma is necessary. In these cases ELISA is still the method of
choice. For further information on MS-based techniques to identify
and quantify oxidative protein modiﬁcations on proteins and
peptides see Rogowska-Wrzesinska et al. [23].Conclusion
When immunoblotting is applied, the results cannot be ex-
pressed in a certain concentration since the method is semi-
quantitative. In this case appropriate controls must be included
(such as untreated cells, etc.). Every researcher should act ac-
cording to good laboratory practice and include appropriate
controls.
When using the spectrophotometric assay or ELISA, most au-
thors present their results in pmol/mg. However, as you can see in
Tables 2 and 4, some authors only express their results in relation
to controls or do not take the protein concentration into con-
sideration. In our opinion, it is inevitable to measure the protein
concentration when assessing protein-bound carbonyls since the
protein concentration is the measure which best corresponds to
the number of modiﬁable residues. Since carbonyl groups on
proteins can arise from a multitude of chemical, thermal and ra-
diation processes it is impossible to link carbonyl groups to a
speciﬁc mechanism. It has been demonstrated that the carbonyl
groups increased linearly in samples treated with iron/ascorbate
[19]. Hence, when measured in complex mixtures such as plasma,
protein carbonyls serve as a biomarker of global protein oxidation.
In a multi-center ring study by Augustyniak et al. [31], six
European laboratories were invited to measure protein carbonyls
according to their own protocol in homogenized liver samples
(UV-radiated and not radiated). Four laboratories used ELISA,
while three used immunoblotting techniques. Unexpectedly, the
concentrations measured by ELISA were quite similar and results
from immunoblotting were also homogenous, indicating that
ELISA techniques (self-prepared standards, quantiﬁcation of stan-
dards by spectrophotometry; commercial kits) represent the best
available method to quantify protein carbonyl concentration,
whereas immunoblotting allows the comparable detection of the
molecular weight of oxidized proteins.
The ring study relies on a review by Rogowska-Wrzesinskaet al. [23] which covers advantages and pitfalls of the most com-
monly used methods and examines commercially available oxi-
dized proteins, oxidants used and lysis buffers. This review, to-
gether with the previous one will help researchers to make a de-
cision which method to use and may lead to a consensus on
common protocols, hence allowing better comparability of results.
Therefore, we are convinced that also in future the detection of
protein carbonyls will be a valuable tool in the detection of oxi-
dative damage, although further improvements in sample stabili-
zation, method robustness and standard design have to be
performed.Acknowledgment
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